Provided by Tiger Trade Technology Pte. Ltd.

YieldMax MRNA Option Income Strategy ETF

19.88
+0.26811.37%
Volume:43.32K
Turnover:853.01K
Market Cap:97.51M
PE:- -
High:19.94
Open:19.56
Low:19.55
Close:19.61
52wk High:37.05
52wk Low:13.60
Shares:4.90M
Float Shares:4.80M
Volume Ratio:5.09
T/O Rate:0.90%
Dividend:18.59
Dividend Rate:93.50%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna President Stephen Hoge Disposes of Common Shares

Reuters
·
16 hours ago

Moderna on Track for Highest Close Since November 2024 -- Data Talk

Dow Jones
·
19 hours ago

BRIEF-Tectonic Therapeutic Appoints François Nader As Chair And Independent Director Of The Board

Reuters
·
Feb 24

Tectonic Therapeutic Appoints FranÇOis Nader, M.d., as Chair and Independent Director of the Board

THOMSON REUTERS
·
Feb 24

Tectonic Therapeutic Inc - Terry Mcguire to Resign as Chair of Tectonic's Board

THOMSON REUTERS
·
Feb 24

Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board

GlobeNewswire
·
Feb 24

Moderna Stock Is Trading Higher Today: What's Going On?

Benzinga
·
Feb 24

Moderately bullish activity in Moderna with shares up 5.92%

TIPRANKS
·
Feb 23

Early notable gainers among liquid option names on February 23rd

TIPRANKS
·
Feb 23

Moderna Shares Hit One-Month High, Last up 7.5%

THOMSON REUTERS
·
Feb 23

Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO

Reuters
·
Feb 23

Moderna price target raised to $69 from $63 at Piper Sandler

TIPRANKS
·
Feb 23

Is Moderna (MRNA) Pricing Reflect Its mRNA Pipeline Potential After 62% Year To Date Rally

Simply Wall St.
·
Feb 23

BREAKINGVIEWS-The Week in Breakingviews: When activists attack

Reuters
·
Feb 23

Moderna Faces Default Risk as Ares Capital–Led Lenders Gain Power to Accelerate Debt and Seize Collateral

TIPRANKS
·
Feb 22

Moderna Stock Soars as Flu Reversal Ignites Hopes

TIPRANKS
·
Feb 21

Moderna posts FY 2025 net product sales of USD 1.82 billion (-42%)

Reuters
·
Feb 21

Mixed options sentiment in Moderna with shares down 0.31%

TIPRANKS
·
Feb 21

Moderna and Merck Advance mRNA Cancer Vaccine Trial in First-Line Lung Cancer: What Investors Should Watch

TIPRANKS
·
Feb 21

BioNTech Sues Moderna Over COVID-19 Vaccine Technology Patent

MT Newswires Live
·
Feb 20